Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Aker BioMarine ASA ( (DE:1PG) ) just unveiled an announcement.
Trond Atle Smedsrud, CEO of Emerging Businesses at Aker BioMarine ASA, recently acquired 6,500 shares in the company through his investment firm HAWI Holding AS, at an average price of NOK 85.72 per share. This transaction, which took place on the Oslo Børs, increases Smedsrud’s total holdings to 19,789 shares, reflecting a significant personal investment in the company and potentially signaling confidence in Aker BioMarine’s market position and future prospects.
More about Aker BioMarine ASA
Aker BioMarine is a leading innovator in human health and nutrition, specializing in krill and algae-derived products. The company’s portfolio includes Superba Krill Oil, Lysoveta, FloraMarine, and PL+, along with the consumer brand Kori Krill. Aker BioMarine also ventures into sustainability with its spin-offs AION and Understory, focusing on plastic waste reduction and protein products, respectively. The company is listed on the Oslo Stock Exchange.
Average Trading Volume: 23,990
Current Market Cap: NOK7.32B
See more data about 1PG stock on TipRanks’ Stock Analysis page.